MARKET

VCYT

VCYT

Veracyte
NASDAQ
45.23
-0.20
-0.44%
After Hours: 45.23 0 0.00% 19:30 09/28 EDT
OPEN
45.04
PREV CLOSE
45.43
HIGH
47.52
LOW
44.47
VOLUME
1.70M
TURNOVER
--
52 WEEK HIGH
60.91
52 WEEK LOW
29.46
MARKET CAP
3.64B
P/E (TTM)
32.24
1D
5D
1M
3M
1Y
5Y
1D
Veracyte Announces Eight Decipher-Focused Studies to Be Presented at ASTRO 2026
Barchart · 3d ago
Veracyte (VCYT) Surges 10.8%: Is This an Indication of Further Gains?
NASDAQ · 3d ago
Quest Diagnostics Stock Gains 36.3% YTD: What's Behind the Rally?
NASDAQ · 3d ago
Here's Why You Should Retain INSP Stock in Your Portfolio for Now
NASDAQ · 5d ago
Cathie Wood Loads Up On Biotech: 5 ETFs Holding Her Latest Bets
Benzinga · 6d ago
Craig-Hallum sees potential for confusion after CMS fee schedule
TipRanks · 6d ago
Is This the Right Time to Add DGX Stock to Your Portfolio?
NASDAQ · 6d ago
Weekly Report: what happened at VCYT last week (0914-0918)?
Weekly Report · 09/21 10:22
More
About VCYT
Veracyte, Inc. is a global diagnostics company. The Veracyte Diagnostics Platform delivers cancer tests that are fueled by broad genomic and clinical data, deep bioinformatic and AI capabilities, and an evidence-generation engine, which drives durable reimbursement and guideline inclusion for its tests. The Company offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna) and bladder cancer (Decipher Bladder and TrueMRD for MIBC). It has developed the noninvasive Percepta Nasal Swab test to help physicians determine lung cancer risk. All of its tests are serviced through its own Clinical Laboratory Improvement Amendments (CLIA) certified laboratories in South San Francisco, California, San Diego, California and Austin, Texas. The Company has acquired the UroAmp platform, which has been clinically validated in non-muscle invasive bladder cancer (NMIBC), including therapy-response monitoring and post-treatment surveillance.

Webull offers Veracyte Inc stock information, including NASDAQ: VCYT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VCYT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VCYT stock methods without spending real money on the virtual paper trading platform.